Fungal infections: diagnostic problems and choice of therapy

Area of Science:

• Medical Mycology
• Infectious Diseases
• Pharmacology

Background:

• Fungi are opportunistic pathogens, often detected late due to diagnostic limitations.
• Traditional guidelines recommend empirical antifungal treatment for persistent fever.
• Newer antifungal drugs present risks and economic burdens, necessitating updated treatment strategies.

Purpose of the Study:

• To evaluate the justification of traditional antifungal treatment guidelines.
• To discuss the role of improved diagnostic tools in managing invasive fungal infections.
• To review current antifungal drug choices and their clinical applications.

Main Methods:

• Review of historical diagnostic limitations in fungal infections.
• Analysis of traditional treatment guidelines versus current evidence.
• Evaluation of safety and efficacy data for antifungal agents, including Amphotericin B formulations and azoles.

Main Results:

• Advanced diagnostic tools allow for earlier detection of invasive fungal infections.
• Empirical antifungal therapy is increasingly questioned due to potential adverse events and costs.
• Liposomal amphotericin B is a key option for aspergillosis, while azoles offer an alternative to conventional Amphotericin B.

Conclusions:

• The paradigm for treating invasive fungal infections is shifting from empirical to targeted therapy.
• Improved diagnostics reduce the need for universal empirical antifungal treatment.
• Optimized antifungal drug selection, considering toxicity and efficacy, is crucial for patient outcomes.